Circulating extracellular vesicles as a potential source of new biomarkers of drug-induced liver injury
- 21 January 2014
- journal article
- review article
- Published by Elsevier in Toxicology Letters
- Vol. 225 (3) , 401-406
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Serum acute phase reactants hallmark healthy individuals at risk for acetaminophen-induced liver injuryGenome Medicine, 2013
- Emerging hepatotoxicity biomarkers and their potential to improve understanding and management of drug-induced liver injuryGenome Medicine, 2013
- Mechanistic Biomarkers Provide Early and Sensitive Detection of Acetaminophen-Induced Acute Liver Injury at First Presentation to HospitalHepatology, 2013
- Current Challenges and Controversies in Drug-Induced Liver InjuryDrug Safety, 2012
- Comparison of protein, microRNA, and mRNA yields using different methods of urinary exosome isolation for the discovery of kidney disease biomarkersKidney International, 2012
- Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseasesHepatology, 2012
- RETRACTED: Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicityJournal of Hepatology, 2012
- Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasmaProceedings of the National Academy of Sciences of the United States of America, 2011
- Candidate biomarkers in exosome‐like vesicles purified from rat and mouse urine samplesProteomics – Clinical Applications, 2010
- Characterization and Comprehensive Proteome Profiling of Exosomes Secreted by HepatocytesJournal of Proteome Research, 2008